These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38906237)

  • 21. SIRT3 sulfhydration using hydrogen sulfide inhibited angiotensin II-induced atrial fibrosis and vulnerability to atrial fibrillation via suppression of the TGF-β1/smad2/3 signalling pathway.
    Hu HJ; Wang XH; Zhang ZZ; Ou Y; Ning ZH; Yang JY; Huang H; Tang HF; Jiang ZS
    Eur J Pharmacol; 2024 Nov; 982():176900. PubMed ID: 39168432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin-3-Gallate Inhibits Atrial Fibrosis and Reduces the Occurrence and Maintenance of Atrial Fibrillation and its Possible Mechanisms.
    Li T; Tong Q; Wang Z; Yang Z; Sun Y; Cai J; Xu Q; Lu Y; Liu X; Lin K; Qian Y
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):895-916. PubMed ID: 37000367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload.
    Shi L; Zhu D; Wang S; Jiang A; Li F
    Am J Hypertens; 2019 Apr; 32(5):452-459. PubMed ID: 30689697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of UCHL1 by LDN-57444 attenuates Ang II-Induced atrial fibrillation in mice.
    Bi HL; Zhang YL; Yang J; Shu Q; Yang XL; Yan X; Chen C; Li Z; Li HH
    Hypertens Res; 2020 Mar; 43(3):168-177. PubMed ID: 31700166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ion channels in chronic intermittent hypoxia-induced atrial remodeling in rats.
    Zhang K; Ma Z; Song C; Duan X; Yang Y; Li G
    Life Sci; 2020 Aug; 254():117797. PubMed ID: 32417371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calcium/calmodulin-dependent protein kinase II causes atrial structural remodeling associated with atrial fibrillation and heart failure.
    Liu Z; Finet JE; Wolfram JA; Anderson ME; Ai X; Donahue JK
    Heart Rhythm; 2019 Jul; 16(7):1080-1088. PubMed ID: 30654134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance.
    Chan YH; Chang GJ; Lai YJ; Chen WJ; Chang SH; Hung LM; Kuo CT; Yeh YH
    Cardiovasc Diabetol; 2019 Sep; 18(1):125. PubMed ID: 31558158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthine oxidase inhibitor allopurinol improves atrial electrical remodeling in diabetic rats by inhibiting CaMKII/NCX signaling.
    Yang Y; He J; Yuan M; Tse G; Zhang K; Ma Z; Li J; Zhang Y; Gao Y; Zhang Y; Wang R; Li G; Liu T
    Life Sci; 2020 Oct; 259():118290. PubMed ID: 32822713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
    Bohne LJ; Jansen HJ; Daniel I; Dorey TW; Moghtadaei M; Belke DD; Ezeani M; Rose RA
    Heart Rhythm; 2021 Jan; 18(1):118-129. PubMed ID: 32911049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
    Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
    Shao Q; Meng L; Lee S; Tse G; Gong M; Zhang Z; Zhao J; Zhao Y; Li G; Liu T
    Cardiovasc Diabetol; 2019 Nov; 18(1):165. PubMed ID: 31779619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
    Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
    Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.
    He X; Gao X; Peng L; Wang S; Zhu Y; Ma H; Lin J; Duan DD
    Circ Res; 2011 Jan; 108(2):164-75. PubMed ID: 21127293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
    Jansen HJ; Mackasey M; Moghtadaei M; Belke DD; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    J Mol Cell Cardiol; 2018 Nov; 124():12-25. PubMed ID: 30273558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction.
    Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA
    Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibrutinib promotes atrial fibrillation by inducing structural remodeling and calcium dysregulation in the atrium.
    Jiang L; Li L; Ruan Y; Zuo S; Wu X; Zhao Q; Xing Y; Zhao X; Xia S; Bai R; Du X; Liu N; Ma CS
    Heart Rhythm; 2019 Sep; 16(9):1374-1382. PubMed ID: 30959203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aliskiren protecting atrial structural remodeling from rapid atrial pacing in a canine model.
    Zhao Z; Chen Y; Li W; Wang X; Li J; Yang W; Cheng L; Liu T; Liu E; Li G
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):863-71. PubMed ID: 27118660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dapagliflozin attenuates myocardial hypertrophy via activating the SIRT1/HIF-1α signaling pathway.
    Yang J; Li L; Zheng X; Lu Z; Zhou H
    Biomed Pharmacother; 2023 Sep; 165():115125. PubMed ID: 37421782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.